We are live on ! Find out more
IMUX icon

Immunic
IMUX

56 hedge funds and large institutions have $23.7M invested in Immunic in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more call options, than puts

Call options by funds: $5.17M | Put options by funds: $3.13M

50% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 12

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

8% more funds holding

Funds holding: 52 → 56 (+4)

84% less capital invested

Capital invested by funds: $146M → $23.7M (-$122M)

Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
18
Reduced
12
Closed
13
Calls
$5.17M
Puts
$3.13M
Net Calls
+$2.04M
Net Calls Change
+$14M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$3.27M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.68M
3
ARTA
A.R.T. Advisors
New York
+$1.34M
4
Northern Trust
Northern Trust
Illinois
+$1.29M
5
State Street
State Street
Massachusetts
+$866K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$27M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.72M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.29M
5
TD Asset Management
TD Asset Management
Ontario, Canada
-$842K

IMUX Hedge Fund Activity: Q3 2015 in Review

56 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2015, worth a combined $23.7M — down 84% from $146M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new IMUX positions and 13 closed out — a net gain of 4 holders — while 18 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $3.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $27M sold.

  • 56 institutional investors held Immunic (IMUX) as of Q3 2015, up from 52 in Q2 2015.
  • Funds reported $23.7M of Immunic stock for Q3 2015, down 84% quarter-over-quarter.
  • 17 funds opened new Immunic positions in Q3 2015 and 13 closed out, a net change of +4 holders.
  • The largest Immunic buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $3.27M added.
  • The largest Immunic seller in Q3 2015 was T. Rowe Price Associates, an estimated $27M sold.

Based on aggregated 13F filings for Q3 2015.